Micro–RNA-126 Reduces the Blood Thrombogenicity in Diabetes Mellitus via Targeting of Tissue Factor

OBJECTIVE—: Diabetes mellitus involves vascular inflammatory processes and is a main contributor to cardiovascular mortality. Notably, heightened levels of circulating tissue factor (TF) account for the increased thrombogenicity and put those patients at risk for thromboembolic events. Here, we soug...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Arterioscler Thromb Vasc Biol
Glavni autori: Witkowski, Marco, Weithauser, Alice, Tabaraie, Termeh, Steffens, Daniel, Kränkel, Nicolle, Witkowski, Mario, Stratmann, Bernd, Tschoepe, Diethelm, Landmesser, Ulf, Rauch-Kroehnert, Ursula
Format: Artigo
Jezik:Inglês
Izdano: Lippincott Williams & Wilkins 2016
Teme:
Translational Sciences
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4894779/
https://ncbi.nlm.nih.gov/pubmed/27127202
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/ATVBAHA.115.306094
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items